Skip to content

Nonacog beta pegol

Refixia (nonacog beta pegol) is a protein pharmaceutical. Nonacog beta pegol was first approved as Refixia on 2017-06-02. It has been approved in Europe to treat hemophilia b.
Trade Name Refixia
Common Name Nonacog beta pegol
Indication hemophilia b
Drug Class Pegylated compounds
Nonacog beta pegol
Get full access now